San Bruno, CA, United States of America

Anna Shcherbina

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Insitro, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Shcherbina. Retrieved from https://idiyas.com/inventor/anna-shcherbina-lhsxgt00

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Shcherbina: Innovator in Machine Learning and Biomarker Discovery

Introduction

Anna Shcherbina is a prominent inventor based in San Bruno, CA (US). She has made significant contributions to the field of machine learning and biomarker discovery. Her innovative work focuses on utilizing standard-of-care data to enhance patient stratification and therapeutic outcomes.

Latest Patents

Anna holds a patent titled "Machine-learning-enabled predictive biomarker discovery and patient stratification using standard-of-care data." This patent relates to the discovery of relevant biomarkers and the stratification of patients through advanced machine learning techniques. The method involves training a machine learning model using medical images and molecular analyte data to predict the activity of molecular analytes in patients.

Career Highlights

Anna is currently employed at Insitro, Inc., where she continues to advance her research in biomarker discovery. Her work is pivotal in identifying patient populations that can benefit from specific therapeutic interventions.

Collaborations

Some of her notable coworkers include Christopher Probert and Zachary Ryan Mccaw, who collaborate with her on various projects within the company.

Conclusion

Anna Shcherbina's contributions to machine learning and biomarker discovery are shaping the future of personalized medicine. Her innovative approaches are paving the way for more effective patient care and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…